Literature DB >> 31808115

Opioid Use Following Bariatric Surgery: Results of a Prospective Survey.

Anne P Ehlers1, Kevin M Sullivan2, Kathryn M Stadeli2, John I Monu2, Judy Y Chen-Meekin2, Saurabh Khandelwal2.   

Abstract

BACKGROUND: Opioid use after bariatric surgery is not clearly understood. Few guidelines exist to inform opioid-prescribing practices after bariatric surgery.
OBJECTIVE: To understand opioid use following bariatric surgery.
SETTING: University hospital.
METHODS: Bariatric surgery patients at a single center were prospectively surveyed at the time of their post-operative visit (January-May 2018). Patients were asked about their opioid use following surgery, whether they received education about opioid use and what they did with leftover medications. Demographic and operative details were obtained from the medical record.
RESULTS: Among 33 patients, the majority (n = 29, 88%) were female with a median age of 40 (20-68) and body mass index of 44.8 (33-78.5). Most patients had leftover narcotics (n = 25, 73%). The median number of pills used was 15 (0-48). Only 12 patients (36%) thought that they had been prescribed "too much" pain medication. Most patients reported receiving education about expectations for post-operative pain (n = 22, 69%); few recalled education about reducing or stopping opioids (n = 13, 40%). More than half of patients (n = 17, 53%) kept their leftover opioids rather than disposing of them or bringing them to an approved turn in location.
CONCLUSIONS: Despite most patients having leftover opioids following surgery, few patients recognized possible overprescription. Education regarding opioid use following surgery is inconsistent, potentially contributing to the amount of retained opioids currently available. Future guidelines should focus on determining the appropriate amount of opioids to be prescribed following surgery and standardizing and improving education given to patients.

Entities:  

Keywords:  Bariatric surgery; Opioids; Patient education

Mesh:

Substances:

Year:  2020        PMID: 31808115      PMCID: PMC8912948          DOI: 10.1007/s11695-019-04301-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  "I didn't see this coming.": why are postbariatric patients in substance abuse treatment? Patients' perceptions of etiology and future recommendations.

Authors:  Valentina Ivezaj; Karen K Saules; Ashley A Wiedemann
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

2.  Trainees as Agents of Change in the Opioid Epidemic: Optimizing the Opioid Prescription Practices of Surgical Residents.

Authors:  Alexander S Chiu; James M Healy; Michael P DeWane; Walter E Longo; Peter S Yoo
Journal:  J Surg Educ       Date:  2017-07-10       Impact factor: 2.891

3.  Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.

Authors:  Henry K Karlsson; Lauri Tuominen; Jetro J Tuulari; Jussi Hirvonen; Riitta Parkkola; Semi Helin; Paulina Salminen; Pirjo Nuutila; Lauri Nummenmaa
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

4.  Correlation Between 24-Hour Predischarge Opioid Use and Amount of Opioids Prescribed at Hospital Discharge.

Authors:  Eric Y Chen; Andrew Marcantonio; Paul Tornetta
Journal:  JAMA Surg       Date:  2018-02-21       Impact factor: 14.766

Review 5.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

6.  Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study.

Authors:  Wendy C King; Jia-Yuh Chen; Steven H Belle; Anita P Courcoulas; Gregory F Dakin; David R Flum; Marcelo W Hinojosa; Melissa A Kalarchian; James E Mitchell; Walter J Pories; Konstantinos Spaniolas; Bruce M Wolfe; Susan Z Yanovski; Scott G Engel; Kristine J Steffen
Journal:  Surg Obes Relat Dis       Date:  2017-04-07       Impact factor: 4.734

7.  Opioid Use After Discharge in Postoperative Patients: A Systematic Review.

Authors:  Adina E Feinberg; Tyler R Chesney; Sanjho Srikandarajah; Sergio A Acuna; Robin S McLeod
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

8.  Effect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery.

Authors:  Margaret E Smith; Jay S Lee; Aaron Bonham; Oliver A Varban; Jonathan F Finks; Arthur M Carlin; Amir A Ghaferi
Journal:  Surg Endosc       Date:  2018-10-23       Impact factor: 4.584

Review 9.  Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review.

Authors:  Mark C Bicket; Jane J Long; Peter J Pronovost; G Caleb Alexander; Christopher L Wu
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  3 in total

1.  Patient characteristics and outcomes among bariatric surgery patients with high narcotic overdose scores.

Authors:  Phillip Yang; Aaron J Bonham; Arthur M Carlin; Jonathan F Finks; Amir A Ghaferi; Oliver A Varban
Journal:  Surg Endosc       Date:  2022-04-11       Impact factor: 4.584

2.  Implementation of a standardized multimodal pain regimen significantly reduces postoperative inpatient opioid utilization in patients undergoing bariatric surgery.

Authors:  Wen Hui Tan; Jordanne Ford; Tammy Kindel; Rana M Higgins; Kathleen Lak; Jon C Gould
Journal:  Surg Endosc       Date:  2022-08-04       Impact factor: 3.453

Review 3.  Opioid prescribing practices following bariatric surgery: a systematic review and pooled proportion meta-analysis.

Authors:  Andrea Lin; Kevin Verhoeff; Valentin Mocanu; Kieran Purich; Khadija Nasser; Janice Y Kung; Daniel W Birch; Shahzeer Karmali; Noah J Switzer
Journal:  Surg Endosc       Date:  2022-08-04       Impact factor: 3.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.